RT-PCR analysis of immune-modulating factors in PBMCs from patients with cancer: reduced IL-2 and increased IL-2-receptor (p55) expression characterize gastroenteric neoplasms
Piancatelli, D.; Cencioni, S.; Di Loreto, S.; Cicia, S.; Adorno, D.; Casciani, C.U.
Anticancer Research 19(2a): 1187-1191
1999
ISSN/ISBN: 0250-7005 PMID: 10368673 Document Number: 508040
Background: To determine the potential contribution of cytokines associated with lymphocyte activation to the pathogenesis of immune impairment in gastroenteric cancer, we examined the expression of cytokine mRNA in peripheral blood mononuclear cells (PBMCs) and tumor-draining lymph nodes (LNs). Material and Methods: Using a reverse transcriptase-polymerase chain reaction (RT-PCR) technique, mRNA transcripts for interleukin (IL)-4, IL-2, IL-5, IL-6, IL-1beta, IFNgamma, IL-10 and IL-2-receptor(IL-2R)(p55) were detected in PBMCs from 16 patients with gastroenteric cancer, undergoing surgical resection, and from 13 healthy donors. Results: Patients expressed a different pattern of cytokines. Significantly increased IL-2R(p55) and reduced IL-2 mRNA expression were found in patients (p=0.034, p=0.043). IL-10 expression was significantly correlated to IL-2R(p55) expression in both groups (p=0.011, p=0.009). In LNs, the results reflected those from PBMCs of the same patient. Conclusions: Gastroenteric cancer showed a suppressive pattern of cytokine expression, suggesting an impairment of T cell activation that can be evidenced from the specific pattern of PBMC cytokine expression.